Post COVID-19 Syndrome in Patients with Asymptomatic/Mild Form.
Malkova, Annа, Kudryavtsev, Igor, Starshinova, Anna et al. · Pathogens (Basel, Switzerland) · 2021 · DOI
Quick Summary
Some people develop long-term symptoms weeks or months after having a mild or even asymptomatic COVID-19 infection. This review found that fatigue, breathing problems, cough, and loss of smell are common in these cases, affecting about 30-60% of patients, mostly women. The researchers suggest these symptoms may be caused by the virus damaging the nervous system or triggering the immune system to attack nerve cells, similar to what happens in chronic fatigue syndrome.
Why It Matters
This study is important because it highlights that ME/CFS-like symptoms can develop after apparently mild COVID-19 infections, particularly in women. Understanding potential autoimmune and neurological mechanisms could help explain why some patients develop severe post-viral fatigue syndromes and may guide future diagnostic and therapeutic approaches for both post-COVID and ME/CFS patients.
Observed Findings
Post-COVID Syndrome develops in an average of 30-60% of patients across analyzed studies.
Female patients predominantly develop PCS after asymptomatic or mild COVID-19.
Fatigue, shortness of breath, cough, and anosmia are the most frequently reported symptoms.
Olfactory loss (anosmia) during mild/asymptomatic disease correlates with later PCS development.
Neurological manifestations suggest possible brain involvement in post-COVID syndrome pathogenesis.
Inferred Conclusions
Female sex and presence of anosmia during acute infection are predictive factors for developing PCS.
Alternative COVID-19 disease pathways may exist in genetically predisposed individuals, characterized by neuronal and immune system targeting.
Post-COVID Syndrome shares pathophysiological features with chronic fatigue syndrome and autoimmune disautonomia, possibly involving autoimmune damage to neurons, glia, and cerebral vessels.
The neurological symptom profile suggests post-COVID syndrome may be driven by immune-mediated neurological dysfunction rather than viral persistence.
Remaining Questions
What specific genetic or immunological factors predispose individuals to develop PCS after mild infections?
What This Study Does Not Prove
This systematic review does not prove that autoimmune neuronal damage causes post-COVID symptoms—it proposes this as a hypothesis based on symptom patterns. The study cannot establish causation or definitively link anosmia and female sex to PCS development; these are identified as associations only. The review also does not directly compare post-COVID syndrome with ME/CFS or establish they are the same condition.